Anpac Bio Abstract-Cancer differentiation analysis technology as a novel technology for cerebral cancer screening.

Cancer-differentiation-analysis-technology-as-a-novel-technology-for-cerebral-cancer-screening

Anpac Bio Abstract- A novel biophysical based marker with multilevel, multiparameter expression for early stage cancer detection.

Read the full article

Sign up for the Anpac Bio newsletter and receive our latest news.

Quick Links

Contact Information

Anpac Technology USA (Anpac Bio)
3 Spring House Innovation Park, Suite 150
Ambler, PA 19002

Email: [email protected]

Phone Number: +1 (267) 810-6776

Anpac Bio-Medical Science Co., Ltd.

Anpac Bio is a biotechnology company focusing on early cancer screening and detection and marketing a suite of cancer detection tests, including CDA (Cancer differentiation analysis), bio-chemistry, immunology, and genomics tests. Anpac has developed a multi-cancer screening and detection test that uses innovative, patented Cancer Differentiation Analysis (CDA) technology and proprietary cancer-detection device.

©2021 Anpac Bio-Medical Science Co., Ltd.
Anpac Bio Launches Major U.S. Expansion, Starting 2nd U.S. Clinical Lab in ...Anpac Bio Abstract- A novel biophysical based marker with multilevel, multiparameter...